Recent Transactions

Caris & Company is proud to announce participation in the following transactions:


  1. $12,500,000

    Underground Solutions

    Common Stock

    Financial Advisor

    December 7th, 2007

  2. $21,000,000

    Response Genetics, Inc.

    IPO

    Co-Manager

    June 5th, 2007

  3. $96,427,500

    Omnicell

    Common Stock

    Co-Manager

    May 22nd, 2007

  4. $17,000,000

    Resverlogix, Inc.

    Senior Secured Convertible Notes

    Co-Manager

    January 5th, 2007

  5. $10,000,000

    Cardax Pharmaceuticals

    Series B Preferred Stock

    January 1st, 2007

  6. $56,940,000

    Nextest Systems

    Common Stock

    Initial Public Offering

    March 21st, 2006

  7. $24,000,000

    SGX Pharmaceuticals

    Common Stock

    Initial Public Offering

    January 31st, 2006

  8. $567,168,000

    Spansion

    Common Stock

    Initial Public Offering

    December 16th, 2005

  9. $0

    California Maintenance, Inc.

    Exclusive Sale

    Sole Manager

    November 15th, 2005

  10. $21,250,000

    Vivus

    Common Stock

    Follow On Offering

    March 10th, 2005

  11. $79,350,000

    Cypress Bioscience

    Common Stock

    Follow On Offering

    April 2nd, 2004

  12. $110,400,000

    Corgentech

    Common Stock

    Initial Public Offering

    February 12th, 2004

  13. $64,000,000

    Esperion Therapeutics

    Common Stock

    Follow On Offering

    July 31st, 2003